US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

19.14

-0.2098-1.08%

Post-market: 19.140.00000.00%19:30 EDT

Volume:127.96K

Turnover:2.44M

Market Cap:112.91M

PE:- -

High:19.20

Open:19.04

Low:18.87

Close:19.35

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:2.99

T/O Rate:2.17%

Dividend:0.71

Dividend Rate:3.73%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Second-Generation Leaders Ascend in China's Pharma Sector, Poised to Steer Industry Transformation

2026 Private Sector Top 500: Three Major Firms Slide Down The Rankings

CSPC Pharmaceutical Group Stock Climbs 1.1% in Hong Kong, Outperforms Competitors

Akeso Says Phase III HARMONi-GI1 Overall Survival Data for Ivonescimab in First-Line Biliary Tract Cancer Wins ESMO Late-Breaking Slot

Innovative Drug Stocks Rally as Index Surges Over 6% on Multiple Positive Catalysts, Led by Key Players

Market Chatter: US Considers Rules Allowing American Investment in Chinese Drugs

MT Newswires Live

Wuxi Biologics (Cayman) Stock Climbs 5.3% in Hong Kong

CSPC Pharmaceutical Group Stock Climbs 7.6% in Hong Kong

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%

China's Roadmap for Pharmaceuticals May Support Sector Development

Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%

WUXI BIO Cancels 39.82 Million Treasury Shares Purchased Under Buyback Program

CSPC Pharmaceutical Group Stock Rises 0.9% in Hong Kong, Outperforms Competitors

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Akeso Wins China NMPA Phase I Clearance for Egfr/trop2 Bispecific ADC Ak158d1

RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales

CICC Raises AKESO Price Target by 8.3% to HK$130, Keeps "Outperform Industry" Rating

CSPC Pharma Begins Diabetes Drug Trial in China

MT Newswires Live

CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/KURE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":19.14,"timestamp":1790971200000,"preClose":19.3498,"halted":0,"volume":127957,"hourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010842489328054955,"floatShares":5899036,"shares":5899036,"eps":0,"marketStatus":"Market Closed","change":-0.2098,"latestTime":"10-02 16:00:00 EDT","open":19.04,"high":19.2,"low":18.87,"amount":2436278.887525,"amplitude":0.017054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.3498,"sharesOutstanding":4750002,"nav":19.06,"aum":112453199.16,"dividendRate":0.037315,"bidAskSpread":0.008807,"postHourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.9854503635447447,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5899036,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.9854503635447447,"shares":5899036,"dividePrice":0.7142,"high":19.2,"amplitude":0.017054,"preClose":19.3498,"low":18.87,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":19.14,"eps":0,"divideRate":0.037315,"volume":127957,"delay":0,"ttmEps":0,"open":19.04,"prevYearClose":17.04,"prevWeekClose":18.72,"prevMonthClose":19.25,"prevQuarterClose":19.25,"fiveDayClose":18.72,"twentyDayClose":18.91,"sixtyDayClose":16.4655},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1147440310","title":"Second-Generation Leaders Ascend in China's Pharma Sector, Poised to Steer Industry Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=1147440310","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147440310?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:40","pubTimestamp":1790080834,"startTime":"0","endTime":"0","summary":"The daughter of \"Madame Oral Liquid\" founder Zhu Baoguo has been nominated as a non-independent director candidate at both his controlled listed firms, Joincare Pharmaceutical Group Industry Co.,Ltd....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","BK0102","IE00B031HY20.USD","LU1152091754.HKD","LU1008478684.HKD","BK0188","LU1226287529.USD","BK0077","LU1807302812.USD","BK0028","300453","KURE","600380","SG9999004220.SGD","IE00BZ08YT58.USD","LU2039709279.SGD","LU1960683339.HKD","BK0251","IE00B543WZ88.USD","BK0187","000513","LU0314109678.HKD","BK0046","IE0008368742.USD","LU0067412154.USD","LU0315179316.USD","LU0880133367.SGD","LU1226287875.USD","LU1152091168.USD","IE00BZ08YS42.EUR","BK0239","LU1328277881.USD","IE00B5MMRT66.SGD","LU0140636845.USD","HK0000165453.HKD","LU1226287792.SGD","BK1515","LU1226288253.USD","688166","01093","LU1226288170.HKD","BK0114","BK1521","LU0326950275.SGD","IE0008369823.USD","300298","IE00BZ08YR35.GBP","LU1813983027.USD","LU1951186391.HKD","LU0072913022.USD","LU1993786604.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170877270","title":"2026 Private Sector Top 500: Three Major Firms Slide Down The Rankings","url":"https://stock-news.laohu8.com/highlight/detail?id=1170877270","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170877270?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:51","pubTimestamp":1790077877,"startTime":"0","endTime":"0","summary":"The All-China Federation of Industry and Commerce released the \"2026 China Top 500 Private Enterprises\" list on September 22nd, showcasing the latest standings of the country's largest private...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","BK0170","SG9999004220.SGD","LU1008478684.HKD","BK1191","IE0008368742.USD","LU0140636845.USD","BK0077","LU0314109678.HKD","LU1951186391.HKD","LU0067412154.USD","IE0008369823.USD","LU1152091168.USD","LU1226288170.HKD","BK1521","LU1226287792.SGD","IE00BZ08YT58.USD","LU0880133367.SGD","IE00B543WZ88.USD","601933","LU1226287875.USD","IE00B031HY20.USD","LU1226288253.USD","LU1328277881.USD","BK0183","LU1813983027.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","IE00BZ08YS42.EUR","01093","LU2039709279.SGD","BK0196","LU0315179316.USD","LU0326950275.SGD","BK0209","KURE","HK0000165453.HKD","LU1226287529.USD","LU1152091754.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669011739","title":"CSPC Pharmaceutical Group Stock Climbs 1.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669011739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669011739?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:33","pubTimestamp":1790065980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 1.1% to 9.71 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25087.75.This was the stock's fifth consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 11% below its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.4%, SSY Group Ltd. rose 0.9%, and United Laboratories International Holdings Ltd. fell 2.2%.Trading volume totaled 83.0 million shares, compared to the 50-day average of 98.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314109678.HKD","LU0072913022.USD","LU1226287875.USD","BK1191","LU1152091168.USD","IE00BZ08YS42.EUR","01093","LU0140636845.USD","LU1951186391.HKD","LU1993786604.SGD","LU1807302812.USD","BK1515","IE0008368742.USD","LU1008478684.HKD","LU0067412154.USD","LU0880133367.SGD","LU0315179316.USD","LU1152091754.HKD","LU1960683339.HKD","BK1521","IE0008369823.USD","SG9999004220.SGD","LU1328277881.USD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1813983027.USD","LU1226288253.USD","IE00B543WZ88.USD","LU2039709279.SGD","HK0000165453.HKD","LU1226287792.SGD","LU1226288170.HKD","KURE","LU1226287529.USD","IE00B031HY20.USD","LU0326950275.SGD","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669365199","title":"Akeso Says Phase III HARMONi-GI1 Overall Survival Data for Ivonescimab in First-Line Biliary Tract Cancer Wins ESMO Late-Breaking Slot","url":"https://stock-news.laohu8.com/highlight/detail?id=2669365199","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669365199?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:47","pubTimestamp":1790034424,"startTime":"0","endTime":"0","summary":"Akeso says Phase III HARMONi-GI1 overall survival data for ivonescimab in first-line biliary tract cancer wins ESMO late-breaking slotAkeso flagged positive overall survival results from a Phase III s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL6gb3DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","LU2476274720.SGD","LU0417516571.SGD","BK1574","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348827113.USD","LU0348825331.USD","LU2399975544.HKD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","LU0417516738.SGD","LU0348783233.USD","LU0348735423.USD","LU0540923850.HKD","LU0348766576.USD","BK1161","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0348767384.USD","09926","LU0634319403.HKD","LU0561508036.HKD","LU0417516902.SGD","LU1720050803.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183882544","title":"Innovative Drug Stocks Rally as Index Surges Over 6% on Multiple Positive Catalysts, Led by Key Players","url":"https://stock-news.laohu8.com/highlight/detail?id=1183882544","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183882544?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:22","pubTimestamp":1789989739,"startTime":"0","endTime":"0","summary":"On September 21, a wave of favorable news hit the market, driving a broad rally in Hong Kong-listed healthcare stocks and marking a strong comeback for innovative drugs. Leading companies saw...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","LU0072913022.USD","LU0501845795.SGD","LU1960683339.HKD","HK0000165453.HKD","LU1152091168.USD","LU1152091754.HKD","520880","LU0140636845.USD","LU0314109678.HKD","LU1328277881.USD","LU1226287875.USD","IE0008369823.USD","IE00B5MMRT66.SGD","KURE","LU2039709279.SGD","SG9999004220.SGD","BK1191","IE00B543WZ88.USD","BK1521","BK1515","IE00BZ08YT58.USD","LU1813983027.USD","01093","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1226288253.USD","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0315179316.USD","LU0067412154.USD","LU1807302812.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1226288170.HKD","LU1993786604.SGD","LU0326950275.SGD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159110","title":"Market Chatter: US Considers Rules Allowing American Investment in Chinese Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159110","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669159110?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:46","pubTimestamp":1789980380,"startTime":"0","endTime":"0","summary":"The U.S. Department of Treasury is planning to introduce rules that would allow American pharmaceuticals to invest in the licensing of Chinese drugs, Reuters reported Sept. 18, citing sources.The rules, which are still subject to change, would cover most of the new drugs under development, except those related to pathogens or biotechnology that can be potentially weaponized, the sources told the news outlet.The news sparked positive sentiment towards Chinese pharmaceuticals on Monday, with Akeso  jumping 10%, Sino Biopharmaceutical  climbing 8%, CSPC Pharmaceutical Group  rising 7%, Innovent Biologics  inching 6% higher and HUTCHMED  increasing 4% at the close.The U.S. Treasury Department did not immediately respond to MT Newswires' request for comment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0561508036.HKD","00013","LU0607220059.USD","LU0314109678.HKD","HCM","BK1515","09926","LU1969619763.USD","LU2778985437.USD","BK1191","BK1583","LU2476274720.SGD","IE00BPRC5H50.USD","LU0634319403.HKD","LU2097828474.EUR","BK1574","IE00B543WZ88.USD","LU2097828805.USD","01801","LU1152091168.USD","LU0348784397.USD","LU0315179316.USD","LU0067412154.USD","LU0463099449.HKD","LU1226287792.SGD","LU2476274308.USD","LU2097828631.EUR","LU2488822045.USD","LU0455707207.USD","LU0149534421.HKD","01093","LU0348825331.USD","KURE","BK1161","BK1588","LU1794554557.SGD","BK1521","IE00BZ08YS42.EUR","LU0348766576.USD","LU2097828714.EUR","LU2399975544.HKD","LU0348767384.USD","LU1328277881.USD","LU0540923850.HKD","LU2242644610.SGD","LU0326950275.SGD","LU1008478684.HKD","LU0244354667.USD","01177","HK0000165453.HKD","BK1589","LU2328871848.SGD","SG9999004220.SGD","LU0140636845.USD","LU1226288253.USD","LU0417516571.SGD","LU1152091754.HKD","LU1831875114.USD","LU1993786604.SGD","LU0502904849.HKD","IE00BZ08YT58.USD","LU1188198961.HKD","SBHMY","LU2039709279.SGD","LU1951186391.HKD","LU0348783233.USD","LU0348735423.USD","LU2097828557.USD","LU1961090484.USD","IE0008368742.USD","LU0880133367.SGD","LU1807302812.USD","LU1226287875.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1813983027.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1720050803.USD","LU0348827113.USD","LU0501845795.SGD","LU1226287529.USD","LU0417516902.SGD","BK1587","LU0417516738.SGD","IE00B031HY20.USD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669215672","title":"Wuxi Biologics (Cayman) Stock Climbs 5.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669215672","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669215672?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:31","pubTimestamp":1789979460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 5.3% to 53.00 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.This was the stock's sixth consecutive day of gains.Wuxi Biologics  Inc. closed 2.7% short of its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 38.6 million shares, compared to the 50-day average of 36.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","LU3063872942.SGD","BK1141","BK1610","LU0327786744.USD","LU0819121731.USD","LU0979878070.USD","02269","LU0348827113.USD","LU0417516738.SGD","IE00B0JY6N72.USD","SG9999002463.SGD","LU0516422952.EUR","LU0043850808.USD","LU0516423091.SGD","LU0634319403.HKD","LU1242518857.USD","LU0588546209.SGD","LU0029874061.USD","LU0359201612.USD","BK1576","LU0359202008.SGD","LU0417516902.SGD","LU0856984785.SGD","LU0051755006.USD","LU0572944931.SGD","LU1880383366.USD","LU1688375341.USD","LU0307460666.USD","KURE","LU0128526141.USD","BK1521","LU0540923850.HKD","SG9999002562.SGD","BK1589","LU0052750758.USD","LU0181495838.USD","LU0708995153.HKD","LU0039217434.USD","LU1794554557.SGD","LU0326950275.SGD","LU0823426480.USD","LU0456827905.SGD","LU0708995583.HKD","LU0348825331.USD","LU0516423174.USD","LU0029874905.USD","LU1242518931.SGD","LU0320764599.SGD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156050","title":"CSPC Pharmaceutical Group Stock Climbs 7.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156050?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:31","pubTimestamp":1789979460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 7.6% to 9.61 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.This was the stock's fourth consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 12% below its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 8.2%, SSY Group Ltd. rose 1.7%, and United Laboratories International Holdings Ltd. rose 3.2%.Trading volume totaled 117.0 million shares, compared to the 50-day average of 97.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU1951186391.HKD","LU0314109678.HKD","LU1226288170.HKD","BK1521","LU1226287529.USD","LU1152091168.USD","IE00B031HY20.USD","01093","IE00BZ08YR35.GBP","LU1226288253.USD","LU0067412154.USD","LU1960683339.HKD","LU1813983027.USD","BK1515","KURE","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU0315179316.USD","LU1226287792.SGD","SG9999004220.SGD","LU0072913022.USD","HK0000165453.HKD","IE0008369823.USD","BK1191","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226287875.USD","LU0880133367.SGD","LU1328277881.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1807302812.USD","LU0501845795.SGD","LU1993786604.SGD","IE0008368742.USD","LU0326950275.SGD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","TFNS","LU2462157665.USD","06978","LU2125154935.USD","LU0203345920.USD","LU0708995153.HKD","LU0455707207.USD","BK1191","LU0516422366.SGD","LU1162221912.USD","BK1515","LU0315179316.USD","01093","LU0880133367.SGD","LU2488822045.USD","LU1506573853.SGD","LU1688375341.USD","02269","LU0463099449.HKD","LU0979878070.USD","LU1226288170.HKD","LU0170899867.USD","LU0516422440.USD","LU0196878994.USD","MEDX","LU0039217434.USD","LU0456846285.SGD","LNGR","LU0708995583.HKD","IE0008368742.USD","IE00BZ08YS42.EUR","LU0516423091.SGD","LU1074936037.SGD","LU0130517989.USD","IE00B5MMRT66.SGD","LU1831875114.USD","LU0823426308.USD","IBBQ","LU0067412154.USD","LGHT","LU0314106906.USD","IYF","IE00BSNM7G36.USD","AGNG","LU0149534421.HKD","LU1668664300.SGD","LU2543165471.USD","LU0417516738.SGD","IE00BZ08YR35.GBP","LU1366192091.USD","BK1610","IE00B543WZ88.USD","BK1100","LU0128525689.USD","SG9999004220.SGD","LU0128522744.USD","LU0607220059.USD","LU0823426480.USD","LU0052756011.USD","BK1576","LU0072461881.USD","LU0516423174.USD","LU1807302812.USD","LU0417516902.SGD","LU0310800965.SGD","LU1226287792.SGD","LU0326950275.SGD","LU1242518857.USD","LU0320765646.SGD","LU0359202008.SGD","FTXO","BK4566","LU0634319403.HKD","LU0140636845.USD","LU1880383366.USD","LU0348735423.USD","C","LU2125154778.USD","BK1574","LU2360032135.SGD","MDEV","LU0181495838.USD","LU0072913022.USD","LU0106831901.USD","LU0029874061.USD","LU0980610538.SGD","BK4504","06990","LU1951186391.HKD","LU0203347892.USD","LU1328277881.USD","BK4534","LU0540923850.HKD","LU1813983027.USD","03347","HK0000165453.HKD","IEIH","LU2417539215.USD","LU1969619763.USD","BK1141","LU0477156953.USD","LU0516422952.EUR","LU0320764243.SGD","BK4588","159992","LU1244550221.USD","LU0130102774.USD","LU0128526141.USD","LU1188198961.HKD","LU1960683339.HKD","LU2236285917.USD","09996","BK4559","LU1144417596.USD","LU2242644610.SGD","01276","SG9999002562.SGD","LU1023057109.AUD","LU2097828631.EUR","LU0588546209.SGD","LU1152091754.HKD","LU1242518931.SGD","SG9999002463.SGD","IE00B031HY20.USD","BK1161","IE00BZ08YT58.USD","LU0327786744.USD","LU0819121731.USD","LU0856984785.SGD","LU2097828714.EUR","LU0501845795.SGD","LU0502904849.HKD","LU0051755006.USD","LU1794554557.SGD","LU0162691827.USD","PTH","BK1589","LU1226287529.USD","BK1521","KURE","LU0348827113.USD","HART","LU0052750758.USD","01801","LU1226288253.USD","LU2097828805.USD","159883","LU1244550494.USD","LU2328871848.SGD","LU1791807156.HKD","LU1720050803.USD","LU0456827905.SGD","LU0359201612.USD","LU1226287875.USD","LU0572944931.SGD","LU2097828474.EUR","LU0359201885.HKD","LU0244354667.USD","LU2097828557.USD","LU0029874905.USD","LU2456880835.USD","LU2039709279.SGD","LU0320764599.SGD","LU1267930227.SGD","BK4585","LU0348825331.USD","LU1201861249.SGD","LU0098860793.USD","BK1583","GDOC","RSPH","LU0043850808.USD","LU1152091168.USD","LU0648001328.SGD","LU1244550577.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1993786604.SGD","LU0561508036.HKD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0307460666.USD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196765579","title":"Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196765579","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196765579?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:41","pubTimestamp":1789962092,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks experienced a broad rally in early trading, with multiple leading companies posting significant gains. As of the latest update, Keymed Bio-B (02162) jumped 9.09% to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","LU2778985437.USD","LU0348784397.USD","IE00BPRC5H50.USD","159992","IE00B5MMRT66.SGD","LU2476274308.USD","LU0540923850.HKD","09926","LU0561508036.HKD","LU0348767384.USD","LU1720050803.USD","BK1574","LU0417516571.SGD","MEDX","LU0348783233.USD","LU0348825331.USD","LU1961090484.USD","LU0417516902.SGD","LU1794554557.SGD","LU2488822045.USD","LU0348766576.USD","LNGR","BK1161","IE00B543WZ88.USD","06978","KURE","IBBQ","LU2476274720.SGD","LU0417516738.SGD","LU2399975544.HKD","LU0348735423.USD","02162","LU0348827113.USD","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669613465","title":"China's Roadmap for Pharmaceuticals May Support Sector Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2669613465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669613465?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:40","pubTimestamp":1789962000,"startTime":"0","endTime":"0","summary":"0340 GMT - China's roadmap for pharmaceuticals that focus on innovation and globalization, appears to lay a good foundation for sector development, says Nomura's Jialin Zhang in a note. The sector's 15th Five-Year Plan targets research-and-development-to-sales ratio of listed pharmaceutical companies averaging higher than 10%, versus the 8% currently estimated by Nomura. It is also targeting first-in-class drugs to account for more than 25% of the global share, says Zhang. The sector's recent rapid development and improved global competitiveness likely spurred the focus on innovation and globalization, says Zhang. The analyst expects pharmaceutical companies and contract research, development, and manufacturing organizations to benefit from the Five-Year Plan. These include Innovent Biologics, WuXi AppTec and WuXi XDC, Zhang adds.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK0216","LU1934453819.USD","HK0000165453.HKD","KURE","BK1583","LU0149534421.HKD","LU1997245094.SGD","SG9999014674.SGD","603259","LU2097828714.EUR","LU1831875114.USD","BK1161","IE00B5MMRT66.SGD","LU0700851271.USD","02268","LU0607220059.USD","LU1303224171.USD","IE00BPRC5H50.USD","LU2097828805.USD","01801","LU2242644610.SGD","LU2097828557.USD","LU0502904849.HKD","LU2328871848.SGD","LU0326950275.SGD","LU0463099449.HKD","LU1997244956.HKD","LU1808992512.USD","LU0244354667.USD","BK1589","LU1969619763.USD","LU0455707207.USD","LU1979443071.USD","LU1770034418.SGD","IE00B543WZ88.USD","LU0611395673.USD","LU2097828631.EUR","BK1141","LU1188198961.HKD","LU1251922891.USD","LU2097828474.EUR","LU1719994722.HKD","LU2495084118.USD","LU1997245177.USD","LU0456842615.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130809094","title":"Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130809094","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130809094?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:53","pubTimestamp":1789955600,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index opened at a standstill on September 21, holding at 24,748.45 points. The Hang Seng Tech Index edged down 0.08% to 4,401.82 points, while the Hang Seng China Enterprises...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","LU1242518857.USD","SGXZ90724238.SGD","00700","LU1785774172.SGD","LU0588546209.SGD","LU0672654166.SGD","LU0048597586.USD","LU0589944569.HKD","LU0061477393.USD","LU2226246903.HKD","SG9999018865.SGD","IE0003895053.USD","LU0106252389.USD","LU0449509016.USD","LU2362540622.SGD","LU0561508036.HKD","LU0791590937.USD","02833","LU1224709979.USD","LU1868837565.USD","LU1883866441.USD","LU2257852520.SGD","XSOE","BK1501","IE00BF5LJ272.USD","LU1769817096.USD","LU0577902538.SGD","IE00B0169L03.USD","LU0314109678.HKD","LU0165289439.USD","LU0048388663.USD","LU1974910355.USD","03088","BK1161","SG9999003461.SGD","LU0348735423.USD","HK0000306701.USD","LU0708995153.HKD","SG9999014880.SGD","BK1521","LU1548497426.USD","LU2328871848.SGD","SG9999000327.SGD","LU0117841782.USD","LU2399975544.HKD","IE0008368742.USD","IE0008368411.USD","LU0543330483.HKD","09088","LU1064131003.USD","HK0000107257.USD","LU2362541513.USD","LU2247934214.USD","LU0348814723.USD","LU1201861165.SGD","LU0509642566.USD","LU0231483743.USD","LU0106259558.USD","LU0307460666.USD","EEMX","LU0642271901.SGD","LU1880398471.USD","SG9999017495.SGD","BK1610","SG9999013353.USD","LU1196710351.USD","IE00B0JY6N72.USD","EMC","LU0918141887.USD","LU1868838027.USD","LU0791591158.USD","LU0049112450.USD","LU0320764755.SGD","LU1655091459.SGD","LU0143863784.USD","03067","IE00BQXX3F31.USD","LU0130518102.USD","07300","03115","LU0868486357.SGD","LU1226287792.SGD","LU0326950275.SGD","LU0541501648.USD","LU0633140727.USD","LU3063872942.SGD","LU1102505762.USD","LU0329678170.USD","HSI","SG9999002828.SGD","JEMA","BK1249","LU0192582467.USD","LU1504937902.USD","IE0003795394.USD","IE00B29SXG58.USD","CXSE","LU0823041008.USD","LU0051755006.USD","LU0738912210.USD","LU2087589342.USD","LU0608807946.USD","LU0797268264.HKD","LU0431992006.USD","LU0328353924.USD","LU0531970944.HKD","LU1044876610.USD","LU0327786744.USD","LU0823039010.USD","LU2279701549.SGD","LU0359201612.USD","LU0594300179.USD","IE00BQXX3C00.GBP","SGXZ62798434.SGD","GAMR","LU0577902371.SGD","LU0675040207.SGD","LU3227948356.SGD","LU2237443978.SGD","LU1993786604.SGD","LU0228659784.USD","BK1095","MCHmain","LU0828237940.HKD","LU0607220059.USD","HBBD.SI","LU2097828805.USD","HTCD.SI","BK1164","LU2362541273.HKD","LU0130103400.USD","LU2125910849.SGD","LU2294711473.HKD","TCEHY","LU0502904849.HKD","LU1328277881.USD","IE00BGV7N243.SGD","03032","LU1316542783.SGD","LU1481107354.HKD","ESPO","LU0117844026.USD","07200","LU0348783233.USD","LU0320764599.SGD","BK1531","SG9999015945.SGD","LU1718418525.SGD","LU2023250504.SGD","LU1804176565.USD","LU1211504680.USD","IE00BZ08YS42.EUR","LU0516422952.EUR","IE00BMPRXR70.SGD","LU0786609619.USD","LU0449515922.USD","LU0348825331.USD","LU0821914370.USD","HK0000288743.USD","LU0396098781.USD","LU0140636845.USD","BK1586","09903","HK0000165453.HKD","LU0823426308.USD","LU0762541174.USD","LU0630378429.USD","LU0611395673.USD","LU1206782309.USD","LU1224444064.USD","SG9999006514.SGD","LU1734074674.USD","FDNI","LU0359202008.SGD","IE00BQXX3D17.EUR","LU1235295612.USD","LU2317271919.USD","GB00BDT5M118.USD","LU0370786039.SGD","SG9999018857.SGD","IE00BZ08YR35.GBP","LU0210527791.USD","LU0878004406.USD","LU2097828474.EUR","SG9999014914.USD","HK0000151867.HKD","LU0261947096.USD","BIDD","SGXZ86797644.SGD","LU2152927971.USD","SG9999001069.SGD","LU0823038988.USD","LU2348773727.SGD","LU0762542818.HKD","HK0000352291.HKD","LU2097828557.USD","LU2177674079.SGD","LU0345769128.USD","HK0000288784.HKD","LU0254981946.USD","LU0737861772.HKD","09115","BK1608","LU2045819591.USD","LU0417516571.SGD","LU0823397103.USD","IE0003851619.USD","07552","LU2008162690.USD","LU0516423174.USD","SG9999000459.SGD","LU0456827905.SGD","BK1604","LU1048588211.SGD","LU1956131251.USD","LU0163747925.USD","LU0886674414.USD","LU0540923850.HKD","06727","LU0516422440.USD","LU0477156797.USD","SG9999006597.SGD","LU0169518387.USD","BABA","01093","LU2153591404.USD","LU1770034418.SGD","IE0008368304.USD","LU1814569148.SGD","LU0878005551.USD","LU1251922891.USD","SG9999014906.USD","LU1769817179.HKD","LU1688375341.USD","LU1439103000.SGD","LU1044874839.SGD","LU2133065610.SGD","SG9999002562.SGD","LU0196878994.USD","LU0831103253.SGD","SGXZ31699556.SGD","IE00B543WZ88.USD","LU0264606111.USD","LU0210526637.USD","LU0348816934.USD","LU1226287875.USD","SG9999001226.SGD","LU0287142896.SGD","SOCL","LU0985320562.USD","LU2293587155.HKD","HK0000320264.USD","LU0173614495.USD","SGXZ99366536.SGD","BK1587","LU1102505929.USD","LU0651947912.USD","LU0197773673.USD","LU0128522744.USD","LU0315179316.USD","IE00B8HQ1Z84.USD","IE00B8L5B284.USD","LU1152091168.USD","LU0873338254.USD","LU2279858448.HKD","KURE","SG9999014674.SGD","LU1868837722.USD","IE0034224299.USD","LU0210533765.USD","LU0630378692.HKD","LU2237443465.HKD","BK1618","LU1152091754.HKD","LU1961090484.USD","LU0039217434.USD","02837","IE00B067MR52.USD","LU1242518931.SGD","09961","LU0594300419.USD","LU0107464264.USD","LU1282648689.USD","LU1323998911.USD","LU0251143458.SGD","LU1720051017.SGD","LU0463099449.HKD","LU0329678337.USD","LU0106959298.USD","LU0572939691.SGD","LU2237443382.USD","LU1969619763.USD","LU2498475776.HKD","BK1591","HK0000286598.CNH","IE00BPRC5H50.USD","LU0143863198.USD","LU0070217475.USD","LU0871576103.HKD","LU2476274720.SGD","KWEB","LU1226287529.USD","LU1880383440.USD","LU0293314216.USD","LU0823426480.USD","09067","LU0164872284.USD","LU1642822792.SGD","03033","LU0516422366.SGD","LU1008478684.HKD","LU0488056044.USD","HK0000914686.HKD","LU0072462343.USD","LU0228367735.SGD","IE00B031HY20.USD","LU0315178854.USD","IE00BMPRXN33.USD","LU0456846285.SGD","LU0700851271.USD","LU1725190679.HKD","LU0084288322.USD","LU0572944931.SGD","LU1048596156.SGD","LU1105468828.SGD","LU1794554557.SGD","LU0882747503.HKD","LU0320764243.SGD","LU0455707207.USD","LU0890818403.SGD","LU0531971595.HKD","BK1609","LU0862451837.USD","LU1880398554.USD","HK0001040168.HKD","LU0456842615.SGD","LU0203345920.USD","LU1960683339.HKD","SG9999015952.SGD","LU0175139822.USD","EMCS","LU0784639295.USD","BK1163","HK0000320223.HKD","LU1171460220.USD","LU0080751232.USD","LU0708995583.HKD","LU1880383366.USD","LU0819123356.HKD","513600","LU1810669033.SGD","LU0651946864.USD","LU2051468812.USD","LU0543330566.HKD","LU0164865239.USD","SG9999001846.SGD","IE0001KFT4U8.USD","LU0259732245.USD","LU1981816686.USD","LU2097828714.EUR","LU1048484197.HKD","07226","LU0261950983.USD","LU0203347892.USD","LU0880133367.SGD","LU0289960550.SGD","AAXJ","LU0072913022.USD","LU0132412106.USD","LU0269904917.USD","LU1366334651.USD","LU1807302812.USD","TCHI","IE00B0169N27.USD","LU1282651048.USD","LU0348723411.USD","LU0096374516.USD","LU0501845795.SGD","LU0762540952.USD","LU1808992512.USD","LU0577902611.USD","IE0032431581.USD","02800","LU1303224171.USD","LU1115378108.SGD","LU0823040885.USD","LU0348784397.USD","LU1023057109.AUD","LU0211977185.USD","LU2488822045.USD","LU0856984785.SGD","LU0683595622.HKD","LU0823413660.USD","LU0605514214.HKD","LU1051768304.USD","BK1109","LU0831093199.SGD","LU2462611646.USD","LU0052750758.USD","LU1366334578.USD","LU0633140560.USD","LU0345769631.USD","LU0441854154.USD","LU1051769294.HKD","TCHmain","LU2039709279.SGD","LU1675838814.USD","IE00B031HW06.USD","LU2424517915.HKD","03423","LU0048580855.USD","LU0348788117.USD","SG9999011746.SGD","LU1719994722.HKD","BK1142","LU0588545730.USD","LU0819121731.USD","LU0593848301.USD","LU0828237510.HKD","03037","IE0031814852.USD","LU1188198961.HKD","LU1733274390.USD","LU0640798160.USD","HSImain","LU0823397285.USD","LU0197773160.USD","LU1917777945.USD","SG9999002463.SGD","SG9999000475.SGD","LU0345775950.USD","03419","LU1733274473.HKD","LU0865486749.SGD","LU0650527681.SGD","LU1282649141.HKD","LU0164880469.USD","LU0149721374.USD","LU1226288253.USD","LU1691799644.USD","LU0214875030.USD","LU0235996351.USD","89988","HTImain","LU2449936058.SGD","BK1584","LU1196710864.SGD","LU0188438112.USD","LU0469268626.HKD","LU0054237671.USD","HSTECH","LU1831875114.USD","SG9999001051.SGD","BK1575","LU0244354667.USD","LU1196710195.USD","SG9999001093.SGD","LU0577902454.USD","SGXZ51526630.SGD","LU0634319403.HKD","LU0499858602.USD","LU1282649067.USD","LU2148510915.USD","LU0181495838.USD","LU1282649810.SGD","LU2097829019.USD","ODDS","HHImain","LU0862451753.SGD","LU1568876251.USD","LU0828238088.HKD","BK1588","83115","BK1516","LU0029875118.USD","01801","LU1568876335.HKD","LU2125910500.SGD","LU2476274308.USD","SG9999000418.SGD","03417","LU0359201885.HKD","HK0001040143.USD","LU0608807433.USD","LU1044875133.USD","LU0588545904.SGD","SGXZ81514606.USD","09988","LU1046422090.SGD","SG9999007991.SGD","LU0572940350.SGD","BK1191","LU0414403682.SGD","LU1770036033.HKD","LU0127658192.USD","SG9999001689.USD","LU1064130708.USD","LU0047713382.USD","LU0541502299.USD","LU0588545490.SGD","LU2251237488.HKD","LU0067412154.USD","LU0972618739.USD","LU0898667661.SGD","LU2778985437.USD","BK1589","LU0384037296.USD","LU2237443622.USD","LU2251237306.USD","LU0499858438.USD","LU0648948544.HKD","LU2357305700.SGD","BK1515","IE00B5MMRT66.SGD","LU0348805143.USD","BK1502","FFEM","TCOM","HK0000352382.USD","LU2242644610.SGD","LU0049853897.USD","BK1517","LU1328615791.USD","SG9999014898.SGD","BK1526","LU0043850808.USD","IE00B97KM107.HKD","BK1615","LU1226288170.HKD","LU0737861699.HKD","LU1282651121.HKD","LU0648000940.SGD","LU0823413587.USD","IE0009570106.USD","IE00B031J352.USD","IE00B3M56506.USD","LU0516423091.SGD","LU0417516738.SGD","LU2237443895.HKD","SG9999015978.USD","LU0211331839.USD","HK0000914660.USD","LU2106854487.HKD","LU0251144936.SGD","IE0008369823.USD","07500","LU0348827113.USD","LU0048575426.USD","LU0417516902.SGD","IE0032834883.USD","LU1439102457.SGD","LU0054450605.USD","LU1226288097.SGD","ALBmain","LU2265009873.SGD","LU0918141705.HKD","LU0261950470.USD","LU1720050803.USD","BKF","LU2237443549.SGD","LU0326948709.USD","SG9999001903.USD","688031","BK1583","LU0128522157.USD","LU0348783662.USD","LU1515016050.SGD","LU1813983027.USD","JADE","LU0029874905.USD","LU0979878070.USD","LU0577902298.EUR","LU0011963245.USD","HK0000306685.HKD","LU0149534421.HKD","LDEM","LU1951186391.HKD","LU2097828631.EUR","SG9999004220.SGD","LU1629966141.USD","LU0229945570.USD","82800","LU1720051108.HKD","SG9999015986.USD","LU0345776255.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127782242","title":"WUXI BIO Cancels 39.82 Million Treasury Shares Purchased Under Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1127782242","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127782242?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:40","pubTimestamp":1789951221,"startTime":"0","endTime":"0","summary":"WUXI BIO (02269) announced that it cancelled 39.8245 million repurchased shares on September 18, 2026.The cancellation involves shares previously bought back by the company as part of its ongoing...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU0307460666.USD","LU0856984785.SGD","LU0359201612.USD","LU0516422952.EUR","LU0516422366.SGD","LU0348825331.USD","LU0043850808.USD","BK1589","LU0140636845.USD","LU1720050803.USD","LU0181495838.USD","LU0128522744.USD","LU0516422440.USD","IE00B0JY6N72.USD","LU0561508036.HKD","LU0634319403.HKD","LU0979878070.USD","LU0417516902.SGD","LU0029874905.USD","LU0516423091.SGD","SG9999002463.SGD","LU0039217434.USD","LU0320764243.SGD","LU0326950275.SGD","LU0456827905.SGD","LU0516423174.USD","LU0051755006.USD","LU0348827113.USD","LU2039709279.SGD","LU0029874061.USD","LU0572944931.SGD","KURE","LU0128526141.USD","LU1688375341.USD","LU0708995583.HKD","BK1576","LU0823426308.USD","LU0320764599.SGD","LU0327786744.USD","LU0823426480.USD","LU1242518931.SGD","LU3063872942.SGD","BK1521","BK1610","LU0417516738.SGD","LU1880383366.USD","LU0456846285.SGD","LU0359202008.SGD","LU0588546209.SGD","SG9999002562.SGD","LU0540923850.HKD","LU0708995153.HKD","LU0052750758.USD","02269","LU0819121731.USD","LU0348735423.USD","BK1141","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668491989","title":"CSPC Pharmaceutical Group Stock Rises 0.9% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2668491989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668491989?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:33","pubTimestamp":1789720380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. inched 0.9% higher to 8.93 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 24750.78.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.5%, SSY Group Ltd. fell 2.0%, and United Laboratories International Holdings Ltd. rose 1.7%.Trading volume totaled 79.1 million shares, compared to the 50-day average of 99.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU0067412154.USD","KURE","LU0880133367.SGD","LU1951186391.HKD","LU1807302812.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","BK1191","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","IE0008368742.USD","BK1515","LU0326950275.SGD","LU1226287529.USD","LU0072913022.USD","LU1960683339.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","LU0315179316.USD","LU1226287792.SGD","LU1226288253.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091168.USD","01093","LU1813983027.USD","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668957642","title":"WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957642","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668957642?lang=en_us&edition=fundamental","pubTime":"2026-09-17 16:10","pubTimestamp":1789632627,"startTime":"0","endTime":"0","summary":"WuXi XDC out-licenses WuXiTecan-2 ADC payload-linker platform to Ona TherapeuticsWuXi XDC out-licensed its WuXiTecan-2 payload-linker platform to Ona Therapeutics for a single-target antibody-drug con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL4Jm48D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0029874061.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516422366.SGD","SG9999002463.SGD","02268","SG9999014674.SGD","LU2039709279.SGD","LU0516423174.USD","LU0456846285.SGD","LU0348827113.USD","BK1141","LU0359201612.USD","LU0348735423.USD","LU0516422952.EUR","LU1688375341.USD","LU0823426480.USD","LU0456827905.SGD","LU1880383366.USD","LU0540923850.HKD","LU0856984785.SGD","LU0140636845.USD","LU0588546209.SGD","LU1794554557.SGD","LU0417516902.SGD","BK1589","BK1576","LU0181495838.USD","LU0819121731.USD","LU0823426308.USD","LU0039217434.USD","LU3063872942.SGD","SG9999002562.SGD","LU0320764599.SGD","LU0463099449.HKD","02269","LU0572944931.SGD","LU0979878070.USD","LU0634319403.HKD","KURE","LU0307460666.USD","LU1188198961.HKD","LU1720050803.USD","LU2488822045.USD","LU0417516738.SGD","LU0708995583.HKD","LU0052750758.USD","LU0348825331.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668951651","title":"Akeso Wins China NMPA Phase I Clearance for Egfr/trop2 Bispecific ADC Ak158d1","url":"https://stock-news.laohu8.com/highlight/detail?id=2668951651","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668951651?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:35","pubTimestamp":1789626955,"startTime":"0","endTime":"0","summary":"Akeso wins China NMPA Phase I clearance for EGFR/TROP2 bispecific ADC AK158D1China’s NMPA cleared a Phase I trial for Akeso’s EGFR/TROP2 bispecific ADC candidate AK158D1 in advanced solid tumors.The d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL48Q7TK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU1794554557.SGD","LU2476274720.SGD","BK1161","LU0348767384.USD","LU2778985437.USD","LU0540923850.HKD","LU0348827113.USD","LU0561508036.HKD","LU0348766576.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","LU2399975544.HKD","BK1574","LU2488822045.USD","LU0348825331.USD","LU2476274308.USD","09926","KURE","LU0348783233.USD","LU0348784397.USD","LU0634319403.HKD","LU1720050803.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113110252","title":"RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1113110252","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113110252?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:20","pubTimestamp":1789626032,"startTime":"0","endTime":"0","summary":"The valuation of innovative drug companies is fundamentally anchored to their pipeline value, and for RemeGen, the PD-1/VEGF bispecific antibody RC148—its core asset in the tumor immunotherapy...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0348767384.USD","LU1064131003.USD","BK1161","LU2778985437.USD","LU2328871848.SGD","IE00B543WZ88.USD","LU0348735423.USD","LU2476274308.USD","BK1574","LU1961090484.USD","09995","IE00BPRC5H50.USD","BK1583","LU1720050803.USD","LU0417516571.SGD","LU0540923850.HKD","LU0634319403.HKD","LU2148510915.USD","LU2476274720.SGD","LU0348827113.USD","LU0561508036.HKD","LU2399975544.HKD","09926","LU0348825331.USD","688331","LU1794554557.SGD","LU0348783233.USD","LU1969619763.USD","LU2488822045.USD","LU0417516738.SGD","LU0348784397.USD","KURE","IE00B5MMRT66.SGD","LU1064130708.USD","LU0417516902.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118931120","title":"CICC Raises AKESO Price Target by 8.3% to HK$130, Keeps \"Outperform Industry\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1118931120","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118931120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:12","pubTimestamp":1789625532,"startTime":"0","endTime":"0","summary":"CICC has released a research report noting that AKESO (09926) announced positive overall survival results from the registrational Phase III clinical trial (HARMONI-2) of its drug AK112, brand name...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELS","LU2488822045.USD","LU1720050803.USD","LU0348783233.USD","LU0348825331.USD","LU0417516738.SGD","LU2778985437.USD","LU2399975544.HKD","LU0417516902.SGD","LU0348784397.USD","LU0417516571.SGD","LU1961090484.USD","LU0634319403.HKD","09926","IE00BPRC5H50.USD","BK1161","EWH","LU0348735423.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348767384.USD","LU2476274720.SGD","LU2476274308.USD","BK1574","LU0348766576.USD","IE00B543WZ88.USD","KURE","LU0348827113.USD","LU1794554557.SGD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667070006","title":"CSPC Pharma Begins Diabetes Drug Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667070006","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667070006?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:06","pubTimestamp":1789556791,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) officially began a phase II clinical trial of SYH2069 injection at the first center in China.The drug is being tested for the treatment of type 2 diabetes mellitus in adult patients, according to a Wednesday bourse filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","LU1960683339.HKD","IE0008368742.USD","LU1993786604.SGD","IE00B543WZ88.USD","LU0067412154.USD","LU1226288170.HKD","LU1226287529.USD","LU1226287875.USD","LU0880133367.SGD","LU1152091168.USD","LU0314109678.HKD","LU1226288253.USD","BK1515","LU0072913022.USD","LU1152091754.HKD","LU1813983027.USD","LU1807302812.USD","LU0140636845.USD","LU1226287792.SGD","IE00BZ08YT58.USD","LU0501845795.SGD","BK1191","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0315179316.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1328277881.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","01093","LU2039709279.SGD","IE0008369823.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150087334","title":"CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1150087334","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150087334?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:40","pubTimestamp":1789555245,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) announced that the Phase II clinical trial for its SYH2069 injection, intended to treat adults with type 2 diabetes, has formally commenced at the first study center in China.The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1226287529.USD","BK1521","KURE","LU1226288253.USD","IE00B543WZ88.USD","BK1191","SG9999004220.SGD","BK1515","LU0315179316.USD","01093","LU0880133367.SGD","LU1226288170.HKD","LU1807302812.USD","LU1226287875.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","IE0008368742.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","PSYK","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091754.HKD","IBBQ","LU0067412154.USD","LU0072913022.USD","IBBJ","MDTX","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU0314109678.HKD","LU1813983027.USD","LU1008478684.HKD","LU1328277881.USD","LU1993786604.SGD","BMED","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}